Rab27a regulates GM-CSF-dependent priming of neutrophil exocytosis

Journal of Leukocyte Biology

Volumn 101, Issue 3, 2017, Pages 693-702

  Ramadass, Mahalakshmi ^a   Johnson, Jennifer Linda ^a   Catz, Sergio D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; Munc13 4; Systemic inflammation; TLR7; TLR9

Indexed keywords

CD11B ANTIGEN; FORMYL PEPTIDE RECEPTOR 1; FORMYLPEPTIDE RECEPTOR; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MYELOPEROXIDASE; RAB27A PROTEIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; PEROXIDASE; RAB PROTEIN; RAB27A PROTEIN, MOUSE; VESICULAR TRANSPORT PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOCYTOSIS; EXOCYTOSIS; MOUSE; NEUTROPHIL; NEUTROPHIL GRANULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; AGONISTS; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; METABOLISM; UPREGULATION;

ANIMALS; ENDOCYTOSIS; EXOCYTOSIS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; NEUTROPHILS; PEROXIDASE; RAB GTP-BINDING PROTEINS; TOLL-LIKE RECEPTOR 9; UP-REGULATION; VESICULAR TRANSPORT PROTEINS;

EID: 85014476468     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3AB0416-189RR     Document Type: Article

References (59)

1. Shi, Y., Liu, C. H., Roberts, A. I., Das, J., Xu, G., Ren, G., Zhang, Y., Zhang, L., Yuan, Z. R., Tan, H. S., Das, G., Devadas, S. (2006) Granulocytemacrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don’t know. Cell Res. 16, 126-133.
2. Hamilton, J. A. (2002) GM-CSF in inflammation and autoimmunity. Trends Immunol. 23, 403-408.
3. Corey, S. J., Rosoff, P. M. (1989) Granulocyte-macrophage colonystimulating factor primes neutrophils by activating a pertussis toxinsensitive G protein not associated with phosphatidylinositol turnover. J. Biol. Chem. 264, 14165-14171.
4. Fleischmann, J. (1986) Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 68, 708-711.
5. Weisbart, R. H., Kwan, L., Golde, D. W., Gasson, J. C. (1987) Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood 69, 18-21.
6. Bayne, L. J., Beatty, G. L., Jhala, N., Clark, C. E., Rhim, A. D., Stanger, B. Z., Vonderheide, R. H. (2012) Tumor-derived granulocytemacrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21, 822-835.
7. Pylayeva-Gupta, Y., Lee, K. E., Hajdu, C. H., Miller, G., Bar-Sagi, D. (2012) Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21, 836-847.
8. Wang, Y., Han, G., Wang, K., Liu, G., Wang, R., Xiao, H., Li, X., Hou, C., Shen, B., Guo, R., Li, Y., Chen, G. (2014) Tumor-derived GM-CSF promotes inflammatory colon carcinogenesis via stimulating epithelial release of VEGF. Cancer Res. 74, 716-726.
9. Wicks, I. P., Roberts, A. W. (2016) Targeting GM-CSF in inflammatory diseases. Nat. Rev. Rheumatol. 12, 37-48.
10. Van Nieuwenhuijze, A., Koenders, M., Roeleveld, D., Sleeman, M. A., van den Berg, W., Wicks, I. P. (2013) GM-CSF as a therapeutic target in inflammatory diseases. Mol. Immunol. 56, 675-682.
11. Hamilton, J. A. (2008) Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8, 533-544.
12. Queen, M. M., Ryan, R. E., Holzer, R. G., Keller-Peck, C. R., Jorcyk, C. L. (2005) Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res. 65, 8896-8904.
13. Fridlender, Z. G., Albelda, S. M. (2012) Tumor-associated neutrophils: friend or foe? Carcinogenesis 33, 949-955.
14. Gregory, A. D., Houghton, A. M. (2011) Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 71, 2411-2416.
15. Zhou, S-L., Dai, Z., Zhou, Z-J, Chen, Q., Wang, Z., Xiao, Y-S., Hu, Z-Q., Huang, X-Y., Yang, G-H., Shi, Y-H., Qiu, S-J., Fan, J., Zhou, J. (2014) CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. Carcinogenesis 35, 597-605.
16. Rao, H.L., Chen, J-W., Li, M., Xiao, Y-B., Fu, J., Zeng, Y-X., Cai, M-Y., Xie, D. (2012) Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients’ adverse prognosis. PLoS One 7, e30806.
17. Li, Y-W., Qiu, S-J., Fan, J., Zhou, J., Gao, Q., Xiao, Y-S., Xu, Y-F. (2011) Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J. Hepatol. 54, 497-505.
18. Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., von der Maase, H. (2009) Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J. Clin. Oncol. 27, 4709-4717.
19. Shen, M., Hu, P., Donskov, F., Wang, G., Liu, Q., Du, J. (2014) Tumorassociated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS One 9, e98259.
20. Fioretti, F., Fradelizi, D., Stoppacciaro, A., Ramponi, S., Ruco, L., Minty, A., Sozzani, S., Garlanda, C., Vecchi, A., Mantovani, A. (1998) Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. J. Immunol. 161, 342-346.
21. Hirose, K., Hakozaki, M., Nyunoya, Y., Kobayashi, Y., Matsushita, K., Takenouchi, T., Mikata, A., Mukaida, N., Matsushima, K. (1995) Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br. J. Cancer 72, 708-714.
22. Lee, L. F., Hellendall, R. P., Wang, Y., Haskill, J. S., Mukaida, N., Matsushima, K., Ting, J. P. (2000) IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration. J. Immunol. 164, 2769-2775.
23. Gutschalk, C. M., Yanamandra, A. K., Linde, N., Meides, A., Depner, S., Mueller, M. M. (2013) GM-CSF enhances tumor invasion by elevated MMP-2,-9, and-26 expression. Cancer Med. 2, 117-129.
24. Faurschou, M., Borregaard, N. (2003) Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5, 1317-1327.
25. Deryugina, E. I., Zajac, E., Juncker-Jensen, A., Kupriyanova, T. A., Welter, L., Quigley, J. P. (2014) Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment. Neoplasia 16, 771-788.
26. Bekes, E. M., Schweighofer, B., Kupriyanova, T. A., Zajac, E., Ardi, V. C., Quigley, J. P., Deryugina, E. I. (2011) Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am. J. Pathol. 179, 1455-1470.
27. Ahn, G. O. O., Brown, J. M. (2008) Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13, 193-205.
28. Hawinkels, L. J., Zuidwijk, K., Verspaget, H. W., de Jonge-Muller, E. S., van Duijn, W., Ferreira, V., Fontijn, R. D., David, G., Hommes, D. W., Lamers, C. B., Sier, C. F. (2008) VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. Eur. J. Cancer 44, 1904-1913.
29. Acuff, H. B., Carter, K. J., Fingleton, B., Gorden, D. L., Matrisian, L. M. (2006) Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res. 66, 259-266.
30. Shang, K., Bai, Y.-P. P., Wang, C., Wang, Z., Gu, H.-Y. Y., Du, X., Zhou, X.-Y. Y., Zheng, C.-L. L., Chi, Y.-Y. Y., Mukaida, N., Li, Y.-Y. Y. (2012) Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice. PLoS One 7, e51848.
31. Wiseman, H., Halliwell, B. (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313, 17-29.
32. Lin, S. C., Chou, Y. C., Wu, M. H., Wu, C. C., Lin, W. Y., Yu, C. P., Yu, J. C., You, S. L., Chen, C. J., Sun, C. A. (2005) Genetic variants of myeloperoxidase and catechol-O-methyltransferase and breast cancer risk. Eur. J. Cancer Prev. 14, 257-261.
33. Ahn, J., Gammon, M. D., Santella, R. M., Gaudet, M. M., Britton, J. A., Teitelbaum, S. L., Terry, M. B., Neugut, A. I., Josephy, P. D., Ambrosone, C. B. (2004) Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res. 64, 7634-7639.
34. Pakakasama, S., Chen, T. T., Frawley, W., Muller, C., Douglass, E. C., Tomlinson, G. E. (2003) Myeloperoxidase promotor polymorphism and risk of hepatoblastoma. Int. J. Cancer 106, 205-207.
35. Cascorbi, I., Henning, S., Brockmöller, J., Gephart, J., Meisel, C., Müller, J. M., Loddenkemper, R., Roots, I. (2000) Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463A of the myeloperoxidase gene. Cancer Res. 60, 644-649.
36. Matsuo, K., Hamajima, N., Shinoda, M., Hatooka, S., Inoue, M., Takezaki, T., Onda, H., Tajima, K. (2001) Possible risk reduction in esophageal cancer associated with MPO-463 A allele. J. Epidemiol. 11, 109-114.
37. Castillo-Tong, D. C., Pils, D., Heinze, G., Braicu, I., Sehouli, J., Reinthaller, A., Schuster, E., Wolf, A., Watrowski, R., Maki, R. A., Zeillinger, R., Reynolds, W. F. (2014) Association of myeloperoxidase with ovarian cancer. Tumour Biol. 35, 141-148.
38. Zhu, H., Yang, L., Zhou, B., Yu, R., Tang, N., Wang, B. (2006) Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study. Carcinogenesis 27, 2491-2496.
39. Schabath, M. B., Spitz, M. R., Zhang, X., Delclos, G. L., Wu, X. (2000) Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis 21, 1163-1166.
40. London, S. J., Lehman, T. A., Taylor, J. A. (1997) Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res. 57, 5001-5003.
41. Taioli, E., Benhamou, S., Bouchardy, C., Cascorbi, I., Cajas-Salazar, N., Dally, H., Fong, K. M., Larsen, J. E., Le Marchand, L., London, S. J., Risch, A., Spitz, M. R., Stucker, I., Weinshenker, B., Wu, X., Yang, P. (2007) Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis. Genet. Med. 9, 67-73.
42. Yang, J.-P. P., Wang, W.-B. B., Yang, X.-X. X., Yang, L., Ren, L., Zhou, F.-X. X., Hu, L., He, W., Li, B.-Y. Y., Zhu, Y., Jiang, H.-G. G., Zhou, Y.-F. F. (2013) The MPO-463G.> A polymorphism and lung cancer risk: a meta-analysis based on 22 case-control studies. PLoS One 8, e65778.
43. Vaguliene, N., Zemaitis, M., Lavinskiene, S., Miliauskas, S., Sakalauskas, R. (2013) Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease. BMC Immunol. 14, 36.
44. Rymaszewski, A. L., Tate, E., Yimbesalu, J. P., Gelman, A. E., Jarzembowski, J. A., Zhang, H., Pritchard, K. A., Jr., Vikis, H. G. (2014) The role of neutrophil myeloperoxidase in models of lung tumor development. Cancers (Basel) 6, 1111-1127.
45. Munafó, D. B., Johnson, J. L., Ellis, B. A., Rutschmann, S., Beutler, B., Catz, S. D. (2007) Rab27a is a key component of the secretory machinery of azurophilic granules in granulocytes. Biochem. J. 402, 229-239.
46. Brzezinska, A. A., Johnson, J. L., Munafo, D. B., Crozat, K., Beutler, B., Kiosses, W. B., Ellis, B. A., Catz, S. D. (2008) The Rab27a effectors JFC1/ Slp1 and Munc13-4 regulate exocytosis of neutrophil granules. Traffic 9, 2151-2164.
47. Johnson, J. L., Hong, H., Monfregola, J., Kiosses, W. B., Catz, S. D. (2011) Munc13-4 restricts motility of Rab27a-expressing vesicles to facilitate lipopolysaccharide-induced priming of exocytosis in neutrophils. J. Biol. Chem. 286, 5647-5656.
48. Johnson, J. L., Monfregola, J., Napolitano, G., Kiosses, W. B., Catz, S. D. (2012) Vesicular trafficking through cortical actin during exocytosis is regulated by the Rab27a effector JFC1/Slp1 and the RhoA-GTPase-activating protein Gem-interacting protein. Mol. Biol. Cell 23, 1902-1916.
49. Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez Gomez, A., Mesa, C., Geilich, M., Winkels, G., Traggiai, E., Casati, A., Grassi, F., Bronte, V. (2010) Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 40, 22-35.
50. Morales, J. K., Kmieciak, M., Knutson, K. L., Bear, H. D., Manjili, M. H. (2010) GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1-bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Res. Treat. 123, 39-49.
51. Kaczanowska, S., Joseph, A. M., Davila, E. (2013) TLR agonists: our best frenemy in cancer immunotherapy. J. Leukoc. Biol. 93, 847-863.
52. Ahn, G. O. O., Tseng, D., Liao, C.-H. H., Dorie, M. J., Czechowicz, A., Brown, J. M. (2010) Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc. Natl. Acad. Sci. USA 107, 8363-8368.
53. He, J., Johnson, J. L., Monfregola, J., Ramadass, M., Pestonjamasp, K., Napolitano, G., Zhang, J., Catz, S. D. (2016) Munc13-4 interacts with syntaxin 7 and regulates late endosomal maturation, endosomal signaling, and TLR9-initiated cellular responses. Mol. Biol. Cell 27, 572-587.
54. Park, B. K., Zhang, H., Zeng, Q., Dai, J., Keller, E. T., Giordano, T., Gu, K., Shah, V., Pei, L., Zarbo, R. J., McCauley, L., Shi, S., Chen, S., Wang, C.-Y. (2007) NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat. Med. 13, 62-69.
55. Serafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V., Borrello, I. (2004) High-dose granulocyte-macrophage colonystimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64, 6337-6343.
56. Wang, Q., Ni, Q., Wang, X., Zhu, H., Wang, Z., Huang, J. (2015) High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival. Med. Oncol. 32, 372.
57. Wang, J-S., Wang, F-B., Zhang, Q-G., Shen, Z-Z., Shao, Z-M. (2008) Enhanced expression of Rab27A gene by breast cancer cells promoting invasiveness and the metastasis potential by secretion of insulin-like growth factor-II. Mol. Cancer Res. 6, 372-382.
58. Dong, W-W., Mou, Q., Chen, J., Cui, J-T., Li, W-M., Xiao, W-H. (2012) Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma. World J. Gastroenterol. 18, 1806-1813.
59. Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C., Nitadori-Hoshino, A., Hoffman, C., Badal, K., Garcia, B. A., Callahan, M. K., Yuan, J., Martins, V. R., Skog, J., Kaplan, R. N., Brady, M. S., Wolchok, J. D., Chapman, P. B., Kang, Y., Bromberg, J., Lyden, D. (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891.